Grants and Contributions:
Title:
COVID-19 - A toolbox for the production of nucleic acid products for vaccines and therapeutics
Agreement Number:
1003190
Agreement Value:
$7,000,000.00
Agreement Date:
Jul 28, 2022 - Mar 22, 2024
Description:
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and delivery vehicles such as lipid nanoparticles which have been demonstrated to be important tools for outbreak management predominately via a mass vaccination approach. The time to market for these products is hindered by complexities in production, production processes, analytical methods, and complicated supply chain, intellectual property landscape and quality management systems. Northern RNA's intention is to provide agile platform production approaches and enabling systems, infrastructure, and resources to ensure access to nucleic acid products and their formulations for researchers, organizations, and healthcare providers in managing the current pandemic and to heighten domestic and global preparedness for the future.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2A 7H8
Reference Number:
172-2022-2023-Q4-1003190
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
717183537
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 22 days.
Amendment Date
Mar 6, 2024
Recipient's Operating Name:
Northern RNA Inc.
Recipient's Legal Name:
NORTHERN RNA INC.
Federal Riding Name:
Calgary Forest Lawn
Federal Riding Number:
48006
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: